The unexhausted potential of E. coli

eLife

Volumn 2015, Issue 4, 2015, Pages

  Blount, Zachary D ^a  

^a BEACON Center for the Study of Evolution in Action ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT DNA; RECOMBINANT PROTEIN; RESTRICTION ENDONUCLEASE; VEROTOXIN;

ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL MUTATION; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIUM ADHERENCE; BACTERIUM CONTAMINATION; BIOFILM; ESCHERICHIA COLI; EVOLUTION; GENETIC CODE; GENETIC ENGINEERING; GENETIC VARIABILITY; GENETICS; HEMOLYTIC ANEMIA; MICROBIAL COMMUNITY; MICROBIOME; MOLECULAR BIOLOGY; MOLECULAR CLONING; NONHUMAN; PATHOGENIC ESCHERICHIA COLI; PATHOTYPE; PHENOTYPIC PLASTICITY; PROTEIN SYNTHESIS INHIBITION; THROMBOCYTOPENIA; ANIMAL; GENOMICS; HOST PATHOGEN INTERACTION; HUMAN; INTESTINE; MICROBIOLOGY; PHYSIOLOGY; PROCEDURES; SCANNING ELECTRON MICROSCOPY; ULTRASTRUCTURE;

RATTUS;

ANIMALS; BIOFILMS; BIOLOGICAL EVOLUTION; ENVIRONMENTAL MICROBIOLOGY; ESCHERICHIA COLI; GENOMICS; HOST-PATHOGEN INTERACTIONS; HUMANS; INTESTINES; MICROSCOPY, ELECTRON, SCANNING;

EID: 85016635869     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/elife.05826     Document Type: Article

References (143)

1. Adlerberth I, Lindberg E, Aberg N, Hesselmar SR, Strannegård IL, Wold A. 2006. Reduced enterobacterial and increased staphylococcal colonization of the infantile bowel: an effect of hygienic lifestyle? Pediatric Research 59:96–101. doi: 10.1203/01.pdr.0000191137.12774.b2.
2. Amato SM, Brynildsen MP. 2014. Nutrient transitions are a source of persisters in Escherichia coli biofilms. PLOS ONE 9:e93110. doi: 10.1371/journal.pone.0093110.
3. Amato SM, Orman MA, Brynildsen MP. 2013. Metabolic control of persister formation in Escherichia coli. Molecular Cell 50:475–487. doi: 10.1016/j/molcel.2013.04.002.
4. Arthur JC, Perez-Chanona E, Mühlbauer M, Tomkovich S, Uronis JM, Ting-Jia Fan, Bampbell BJ, Abujamel T, Dogan B, Rogers AB, et al. 2012. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338:120–123. doi: 10.1126/science.1224820.
5. Azad MB, Konya T, Maughan H, Guttman DS, Field CJ, Chari RS, Sears MR, Becker AB, Scott JA, Kozyrkyi AL, et al. 2013. Gut microbiota of healthy Canadian infants: profiles by mode of delivery and infant diet at 4 months. Canadian Medical Association Journal 185:385–394. doi: 10.1503/cmaj.121189.
6. Bäckhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. 2005. Host-bacterial mutualism in the human intestine. Science 307:1915–1920. doi: 10.1126science.1104816.
7. Balaban NQ, Merrin J, Chait R, Kowalik L, Leibler S. 2004. Bacterial persistence as a phenotypic switch. Science 305:1622–1625. doi: 10.1126/science.1099390.
8. Barrick JE, Yu DS, Yoon SH, Oh TK, Schneider D, Lenski RE, Kim JF. 2009. Genome evolution and adaptation in a long-term experiment with Escherichia coli. Nature 461:1243–1247. doi: 10.1038/nature08480.
9. Beloin C, Roux A, Ghigo JM. 2008. Escherichia coli biofilms. Current Topics in Microbiology and Immunology 322:249–289. doi: 10.1007/978-3-540-75418-3_12.
10. Bentley R, Meganathan R. 1982. Biosynthesis of vitamin K (menaquinone) in bacteria. Microbiological Reviews 46:241–280.
11. Berthe T, Ratajczak M, Clermont O, Denamur E, Petit F. 2013. Evidence for coexistence of distinct Escherichia coli populations in various aquatic environments and their survival in estuary water. Applied and Environmental Microbiology 79:4684–4693. doi: 10.1128/AEM.00698-13.
12. Bigger JW. 1944. Treatment of Staphylococcal infections with penicillin. Lancet 244:497–500. doi: 10.1016/S0140-6736(00)74210-3.
13. Bitzan M. 2009. Treatment options for HUS secondary Echerichia coli O157:H7. Kidney International Supplement 75:S62–S66. doi: 10.1038/ki.2008.624.
14. Blattner FR, Plunkett G III, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, et al. 1997. The complete genome sequence of Escherichia coli K-12. Science 277: 1453–1462. doi: 10.1126/science.277.5331.1453.
15. Blount ZD, Barrick JE, Davidson CJ, Lenski RE. 2012. Genomic analysis of a key innovation in an experimental Escherichia coli population. Nature 489:513–518. doi: 10.1038/nature11514.
16. Blount ZD, Borland CZ, Lenski RE. 2008. Historical contingency and the evolution of a key innovation in an experimental population of Escherichia coli. Proceedings of the National Academy of Sciences of USA 105:7899–7906. doi: 10.1073/pnas.0803151105.
17. Bollinger RR, Everett ML, Palestrant D, Love SD, Lin SS, Parker W. 2003. Human secretory immunoglobulin A may contribute to biofilm formation in the gut. Immunology 109:580–587. doi: 10.1046/j.1365-2567.2003.01700.x.
18. Bordet J, Ciuca M. 1921. Remarques sur l’historique des recherches, concernant la lyse microbienne transmissible. Comptes Rendus Biologies 84:745–747.
19. Brennan FP, Abram F, Chinalia FA, Richards KG, O’Flaherty. 2010. Characterization of environmentally persistent Escherichia coli isolates leached from an Irish soil. Applied and Environmental Microbiology 76: 2175–2180. doi: 10.1128/AEM.01944-09.
20. Brenner DJ, Farmer JJ III. 2007. Family I. Enterobacteriaceae Rhn 1937, Nom. Fam. Cons. Opin. 15, Jud. Comm. 1958a, 73, Ewing, Farmer, and Brenner 1980, 674; Judicial Commission 1981, 104. In: Garrity G, Brenner DJ, Krieg NR, Staley JR. Bergey’s Manual of Systematic Bacteriology, Volume 2. The Proteobacteria, Part B: The Gammaproteobacteria. New York: Springer. p. 587–850.
21. Bronfenbrenner JJ. 1932. The heat inactivation of bacteriophages. Proceedings of the Society for Experimental Biology and Medicine 29:802–804. doi: 10.3181/00379727-29-6087.
22. Bronfenbrenner JJ, Korb C. 1925. Studies on the bacteriophage of d’Herelle: II. effect of alcohol on the bactiophage of d’Herelle. Journal of Experimental Medicine 42:419–429. doi: 10.1084/jem.42.3.419.
23. Bruschi F, Dundar M, Gahan K, Gartland M, Szente M, Viola-Magni MP, Akbarova Y. 2011. Biotechnology worldwide and the ‘European biotechnology Thematic Network’ association (EBTNA). Current Opinion in Biotechnology 22(Suppl 1):S7–S14. doi: 10.1016/j.copbio.2011.05.506.
24. Callaway TR, Carr MA, Edrington TS, Anderson RC, Nisbet DJ. 2009. Diet, Escherichia coli O157:H7, and cattle: a review after 10 years. Current Issues in Molecular Biology 11:67–79.
25. Callaway TR, Edrington TS, Nisbet DJ. 2014. Isolation of Escherichia coli O157:H7 and Salmonella from migratory brown-headed cowbirds (Molothrus ater), common Grackles (Quiscalus quiscula), and cattle egrets (Bubulcus ibis). Foodborne Pathogens and Disease 11:791–794. doi: 10.1089/fpd.2014.1800.
26. Capaldi RA, Schulenberg B, Murray J, Aggeler R. 2000. Cross-linking and electron microscopy studies of the structure and functioning of the Escherichia coli ATP synthase. Journal of Experimental Biology 203:29–33.
27. Chang DE, Smalley DJ, Tucker DL, Leatham MP, Norris WE, Stevenson SJ, Anderson AB, Grissom JE, Laux DC, Cohen PS, et al. 2004. Carbon nutrition of Escherichia coli in the mouse intestine. Proceedings of the National Academy of Sciences of USA 101:7427–7432. doi: 10.1073/pnas.0307888101.
28. Chao L, Levin BR. 1977. Complex community in a simple habitat: experimental study with bacteria and phage. Ecology 58:369–378. doi: 10.2307/1935611.
29. Chen X, Zhou L, Tian K, Kumar A, Singh S, Prior BA, Wang Z. 2013. Metabolic engineering of Escherichia coli: a sustainable industrial platform for bio-based chemical production. Biotechnology Advances 31:1200–1223. doi: 10.1016/j.biotechadv.2013.02.009.
30. Claesson MJ, O’Sullivan O, Wang Q, Nikkilaä J, Marchesi JR, Smidt H, de Vos WM, Ross RP, O’Toole PW. 2009. Comparative analysis of pyrosequencing and a phylogenetic microarray for exploring microbial community structures in the human distal intestine. PLOS ONE 4:e6669. doi: 10.1371/journal.pone.0006669.
31. Cohen S, Chang A, Boyer H, Helling R. 1973. Construction of biologically functional bacterial plasmids in vitro. Proceedings of the National Academy f Sciences of USA 70:3240–3244. doi: 10.1073/pnas.70.11.3240.
32. Cooper TF. 2007. Recombination speeds adaptation by reducing competition between beneficial mutations in populations of Escherichia coli. PLOS Biology 5: 1899–1905. doi: 10.1371/journal.pbio.0050225.
33. Cooper TF, Rozen DE, Lenski RE. 2003. Parallel changes in gene expression after 20,000 generations of evolution in Escherichia coli. Proceedings of the National Academy of Sciences of USA 100:1072–1077. doi: 10.1073/pnas.0334340100.
34. Crick FH, Barnett L, Brenner S, Watts-Tobin RJ. 1961. General nature of the genetic code for proteins. Nature 192:1227–1232. doi: 10.1038/1921227a0.
35. Daegelen P, Studier FW, Lenski RE, Cure S, Kim JF. 2009. Tracing ancestors and relatives of Escherichia coli B, and the derivation of B strains REL606 and BL21 (DE3). Journal of Molecular Biology 394:634–643. doi: 10.1016/j.jmb.2009.09.022.
36. de Muinck EJ, Lagesen K, Afset JE, Didelot X, Rønningen KS, Rudi K, Stenseth NC, Trosvik P. 2013. Comparisons of infant Escherichia coli isolates link genomic profiles with adaptation to the ecological niche. BMC Genomics 14:81. doi: 10.1186/1471-2164-14-81.
37. Dolbrindt U, Chowdary MG, Krumbholz G, Hacker J. 2010. Genome dynamics and its impact on evolution of Escherichia coli. Medical Microbiology and Immunology 199:145–154. doi: 10.1007/s00430-010-0161-2.
38. Dublan MD, Ortiz-Marquez JCF, Lett L, Curatti L. 2014. Plant-adapted Escherichia coli show increased lettuce colonizing ability, resistance to oxidative stress and chemotactic response. PLOS ONE 9:e110416. doi: 10.137/journal.pone.0110416.
39. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargen M, Bill SR, Nelson KE, Relman DA. 2005. Diversity of the human intestinal microbial flora. Science 308:1635–1638. doi: 10.1126/science.1110591.
40. Ellis EL, Delbrü ck M. 1939. The growth of bacteriophage. Journal of General Physiology 22: 365–384. doi: 10.1085/jgp.22.3.365.
41. Englesberg E, Irr J, Power J, Lee N. 1965. Positive control of enzyme synthesis by gene C in the Larabinose system. Journal of Bacteriology 90:946–957.
42. Escherich T. 1988. The intestinal bacteria of the neonate and breast-fed infant (1885). Review of Infectious Disease 10:1220–1225.
43. Feeney AR, Cooke EM, Shinebaum R. 1980. A comparative study of gram-negative aerobic bacilli in the faeces of babies born in hospital and at home. Journal of Hygiene 77:129–139. doi: 10.1017/S0022172400026565.
44. Ferens WA, Hovde CJ. 2011. Escherichia coli O157:H7: Animal reservoir and sources of human infection. Foodborne Pathogens and Disease 8:465–487. doi: 10.1089/fpd.2010.0673.
45. Frenzen PD, Drake A, Angulo FJ, The Emerging infections Program Foodnet working group. 2005. Economic cost of illness due to Escherichia coli O157 infections in the United States. Journal of Food Protection 68:2623–2630.
46. Griffin PM, Ostroff SM, Tauxe RV, Greene KD, Wells JG, Lewis JH, Blake PA. 1988. Illnesses associated with Escherichia coli O157:H7 infections. a broad clinical spectrum. Annals of Internal Medicine 109:705–712. doi: 10.7326/0003-4819-109-9-705.
47. Griffin PM, Tauxe RV. 1991. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiologic Review 13: 60–98.
48. Gronlund MM, Lehtonen OP, Eerola E, Kero P. 1999. Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery. Journal of Pediatric Gastroenterology and Nutrition 28:19–25. doi: 10.1097/00005176-199901000-00007.
49. Guttman DS, Dykhuizen DE. 1994. Clonal divergence in Escherichia coli as a result of recombination, not mutation. Science 266:1380–1383. doi: 10.1126/science.7973728.
50. Hansen S, Lewis K, Vulic´ M. 2008. Role of global regulators and nucleotide metabolism in antibiotic tolerance in Escherichia coli. Antimicrobial Agents and Chemotherapy 52:2718–2726. doi: 10.1128/AAC.00144-08.
51. Harshey RM. 2003. Bacterial motility on a surface: many ways to a common goal. Annual Reviews of Microbiology 57:249–273. doi: 10.1146/annurev.micro57.030502.091014.
52. Harshey RM, Matsuyama T. 1994. Dimorphic transition in Escherichia coli and Salmonella typhimurium: surfaceinduced differentiation into hyperflagellate swarmer cells. Proceedings of the National Academy of Sciences of USA 91:8631–8635. doi: 10.1073/pnas.91.18.8631.
53. Hartl DL, Dykhuizen DE. 1984. The population genetics of Escherichia coli. Annual Review of Genetics 18: 1–68. doi: 10.1146/annurev.ge.18.120184.000335.
54. He X, Mishchuk DO, Shah J, Weimer BC, Slupsky CM. 2013. Cross-talk between E. coli strains and a human colorectal adenocarcinoma-derived cell line. Scientific Reports 3:3416. doi: 10.1038/srep03416.
55. Herring CD, Glasner JD, Blattner FR. 2003. Gene replacement without selection: regulated suppression of amber mutations in Escherichia coli. Gene 5: 153–163. doi: 10.1016/S0378-1119(03)00585-7.
56. Hildebrand A, Schlacta T, Warmack R, Kasuga T, Fan Z. 2013. Engineering Escherichia coli for improved ethanol production from gluconate. Journal of Biotechnology 168:101–106. doi: 10.1016/j.jbiotec.2013.07.033.
57. Hobby GL, Meyer K, Chaffee E. 1942. Observations on the mechanism of action of penicillin. Experimental Biology and Medicine 50:281–285. doi: 10.3181/00379727-50-13773.
58. Hu Y, Coates AR. 2005. Transposon mutagenesis identifies genes which control antimicrobial drug tolerance in stationary-phase Escherichia coli. FEMS Microbiology Letters 243:117–124. doi: 10.1016/j.femsle.2004.11.049.
59. Huang C, Lin H, Yang X. 2012. Industrial production of recombinant therapeutics in Escherichia coli and its recent advancements. Journal of Industrial Microbiology & Biotechnology 39:383–399. doi: 10.1007/s10295-011-1082-9.
60. Inoue T, Shingaki R, Hirose S, Waki K, Mori H, Fukui K. 2007. Genome-wide screening of genes required for swarming motility in Escherichia coli. Journal of Bacteriology 189:950–957. doi: 10.1128/jb.01294-06.
61. Ishii S, Sadowsky MJ. 2008. Escherichia coli in the environment: implications for water quality and human health. Microbes and Environments 23:101–108. doi: 10.1264/jsme2.23.101.
62. Jacob F, Monod J. 1961. Genetic regulatory mechanisms in the synthesis of proteins. Journal of Molecular Biology 3:318–356. doi: 10.1016/S0022-2836(61)80072-7.
63. Jacob F, Perrin D, Sanchez C, Monod J. 1960. L’opéron: groupe de génesá expression coordonné par un opérateur (The operon: a group of genes whose expression is coordinated by an operator). Comptes Rendus Hebdomadaires Des Séances De l’Académie Des Sciences 250:1727–1729. doi: 10.1016/j.crvi.2005. 04.005.
64. Janßen HJ, Steinbüchel A. 2014. Fatty acid synthesis in Escherichia coli and its applications towards the production of fatty acid based fiofuels. Biotechnology for Biofuels 7:7. doi: 10.1186/1754-6834-7-7.
65. Judson HF. 1996. The Eighth Day of Creation. Cold Spring Harbor: Cold Spring Harbor Press.
66. Kaas RS, Friis C, Ussery DW, Aarestrup FM. 2012. Estimating variation within the genes and inferring the phylogeny of 186 sequenced diverse Escherichia coli genomes. BMC Genomics 13:577. doi: 10.1186/1471-2164-13-577.
67. Kamionka M. 2011. Engineering of therapeutic proteins production in Escherichia coli. Current Pharmaceutical Biotechnology 12:268–274. doi: 10.2174/138920111794295693.
68. Kaper JB, Nataro JP, Mobley HLT. 2004. Pathogenic Escherichia coli. Nature Reviews Microbiology 2: 123–140. doi: 10.1038/nrmicro818.
69. Kasarjian JKA, Iida M, Ryu J. 2003. New restriction enzymes discovered from Escherichia coli clinical strains using a plasmid transformation method. Nucleic Acids Research 31:e22. doi: 10.1093/nar/gng022.
70. Kaup B, Bringer-Meyer S, Sahm H. 2004. Metabolic engineering of Escherichia coli: construction of an efficient biocatalyst for D-mannitol formation in a whole-cell biotransformation. Applied Microbiology and Biotechnology 64:333–339. doi: 10.1007/s00253-003-1470-9.
71. Kawecki TJ, Lenski RE, Ebert D, Hollis B, Olivieri I, Whitlock MC. 2013. Experimental evolution. Trends in Ecology & Evolution 27:547–560. doi: 10.1016/j.tree.2012.06.001.
72. Kim B, Park H, Na D, Lee SY. 2014. Metabolic engineering of Escherichia coli for the production of phenol from glucose. Biotechnology Journal 9:621–629. doi: 10.1002/biot.201300263.
73. Koren O, Goodrich JK, Cullender TC, Spor A, Laitinen K, Cling BH, Gonzalez A, Werner JJ, Angenent LT, Knight R, et al. 2012. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell 150:470–480. doi: 10.1016/j.cell.2012.07.008.
74. Lawrence JG, Roth JR. 1996. Evolution of coenzyme B12 synthesis among enteric bacteria: evidence for loss and acquisition of a multigene complex. Genetics 143: 11–24.
75. Lehman IR, Bessman MJ, Simms ES, Kornberg A. 1958. Enzymatic synthesis of deoxyribonucleic acid. I. Preparation of substrates and partial purification of an enzyme from Escherichia coli. Journal of Biological Chemistry 233:163–170.
76. Leimbach A, Hacker J, Dobrindt U. 2013. E. coli as an all-rounder: the thin line between commensalism and pathogenicity. Current Topics in Microbiology and Immunology 358:3–32. doi: 10.1007/82_2012_303.
77. Lewis K. 2010. Persister cells. Annual Reviews of Microbiology 64:357–372. doi: 10.1146/annurev.micro.112408.134306.
78. Lindberg E, Adlerberth I, Hesselmar B, Saalman R, Strannegard IL, Aberg N, Wold AE. 2004. High rate of transfer of Staphylococcus aureus from parental skin to infant gut flora. Journal of Clinical Microbiology 42:530–534. doi: 10.1128/JCM.42.2.530-534.2004.
79. Lindberg E, Nowrouzian F, Adlerberth I, Wold AE. 2000. Long-time persistence of superantigenproducing Staphylococcus aureus strains in the intestinal microflora of healthy infants. Pediatric Research 48:741–747. doi: 10.1203/00006450-200012000-00007.
80. Link AJ, Phillips D, Church GM. 1997. Methods for generating precise deletions and insertions in the genome of wild-type Escherichia coli: applications to open reading frame characterization. Journal of Bacteriology 179:6228–9237.
81. Linn S, Arber W. 1968. Host specificity of DNA produced by Escherichia coli. X. In vitro restriction of phage fd replicative form. Proceedings of the National Academy of Sciences of USA 59:1300–1306. doi: 10.1073/pnas.59.4.1300.
82. Liu T, Khosla C. 2010. Genetic engineering of Escherichia coli for biofuel production. Annual Review of Genetics 44:53–69. doi: 10.1146/annurev-genet-102209-163440.
83. Lopez-Torres AJ, Hazen TC, Toranzos GA. 1987. Distribution and in situ survival and activity of Klebsiella pneumonia and Escherichia coli in a tropical rain forest watershed. Current Microbiology 15:213–218. doi: 10.1007/BF01577533.
84. Lukjancenko O, Wassenaar TM, Ussery DW. 2010. Comparison of 61 sequenced Escherichia coli genomes. Microbial Ecology 60:708–720. doi: 10.1007/s00248-010-9717-3.
85. Lederberg J, Lederberg E. 1952. Replica plating and indirect selection of bacterial mutants. Journal of Bacteriology 63:399–406.
86. Lenski RE. 1988. Experimental studies of pleiotropy and epistasis in Escherichia coli. I. variation in competitive fitness among mutants resistant to virus T4. Evolution 42:425–432. doi: 10.2307/2409028.
87. Lenski RE. 2004. Phenotypic and genomic evolution during a 20,000 generation experiment with the bacterium Escherichia coli. Plant Breeding Reviews 24: 225–265. doi: 10.1002/9780470650288.ch8.
88. Luria SE, Delbruck M. 1943. Mutations of bacteria from virus sensitivity to virus resistance. Genetics 28: 491–511.
89. Lwoff A. 1953. Lysogeny. Bacteriology Reviews 17: 269–337.
90. Mead PS, Slutsker L, Dietz V, McCraig LF, Bresee JS, Shapiro C, Griffin PM, Tauxe RV. 1999. Food-related illness and death in the United States. Emerging Infectious Diseases 5:607–625. doi: 10.3201/eid0505.990502.
91. Meselson M, Yuan R. 1968. DNA restriction enzyme from E. coli. Nature 217:1110–1114. doi: 10.1038/2171110a0.
92. Meyer JR, Agrawal AA, Quick RT, Dobias DT, Schneider D, Lenski RE. 2010. Parallel changes in host resistance to viral infection during 45,000 generations of relaxed selection. Evolution 60:3024–3034. doi: 10.1111/j.1558-5646.2010.01049.x.
93. Meyer JR, Dobias DT, Weitz JS, Barrick JE, Quick RT, Lenski RE. 2012. Repeatability and contingency in the evolution of a key innovation in phage lambda. Science 335:428–432. doi: 10.1126/science.1214449.
94. Minot S, Sinha R, Chen J, Li H, Keilbaugh SA, Wu GD, Lewis JD, Bushman FD. 2011. The human gut virome: inter-individual variation and dynamic response to diet. Genome Research 21:1616–1625. doi: 10.1101/gr.122705.111.
95. Mira A, Martin-Cuadrado AB, D’Auria G, Rodríguez-Valera F. 2010. The bacterial pan-genome: a new paradigm in microbiology. International Microbiology 12:45–57. doi: 10.2436/20.1501.01.110.
96. Moeller AH, Li Y, Ngole EM, Ahuka-Mundeke S, Lonsdorf EV, Pusey AE, Peeters M, Hahn BH, Ochman H. 2014. Rapid changes in the gut microbiome during human evolution. Proceedings of the National Academy of Sciences of USA 111:16431–16435. doi: 10.1073/pnas.1419136111.
97. Nascimento HH, Silva LE, Souza RT, Silva NP, Scaletsky IC. 2014. Phenotypic and genotypic characteristics associated with biofilm formation in clinical isolates of atypical enteropathogenic Escherichia coli (aEPEC) strains. BMC Microbiology 14:184. doi: 10.1186/1471-2180-14-184.
98. Nesse LL, Sekse C, Berg K, Johannesen KC, Solheim H, Vestby LK, Urdahl AM. 2014. Potentially pathogenic Escherichia coli can form a biofilm under conditions relevant to the food production chain. Applied and Environmental Microbiology 80:2042–2049. doi: 10.1128/AEM.03331-13.
99. Nowrouzian F, Hesselmar B, Saalman R, Strannegard I, Aberg N, Wold AE, Adlerberth I. 2003. Escherichia coli in infants’ intestinal microflora: colonization rate, strain turnover, and virulence gene carriage. Pediatric Research 54:8–14. doi: 10.1203/01.PDR.0000069843.20655.EE.
100. Neu J, Rushing J. 2011. Cesarean versus vaginal delivery: long-term infant outcomes and the hygiene hypothesis. Clinics in Perinatology 38:321–331. doi: 10.1016/j.clp.2011.03.008.
101. Nirenberg M, Leder P, Bernfield M, Brimacombe R, Trupin J, Rottman F, O’Neal C. 1965. RNA codewords and protein synthesis, VII. On the general nature of the RNA code. Biochemistry 53:1161–1168. doi: 10.1073/pnas.53.5.1161.
102. Partridge JD, Harshey RM. 2013a. More than motility: Salmonella flagella contribute to overriding friction and facilitating colony hydration during swarming. Journal of Bacteriology 195:919–929. doi: 10.1128/jb.02064-12.
103. Partridge JD, Harshey RM. 2013b. Swarming: flexible roaming plans. Journal of Bacteriology 195:909–918. doi: 10.1128/jb.02063-12.
104. Paul S, Linardopoulou EV, Billig M, Tchesnokova V, Price LB, Johnson JR, Chattopadhyay S, Sokurenko EV. 2013. Role of homologous recombination of extraintestinal Escherichia coli. Journal of Bacteriology 195:231–242. doi: 10.1128/JB.01524-12.
105. Ponciano JM, La HJ, Joyce P, Forney LJ. 2009. Evolution of diversity in spatially structured Escherichia coli populations. Applied and Environmental Microbiology 75:6047–6054. doi: 10.1128/AEM.00063-09.
106. Pupo GM, Lan R, Reeves PR. 2000. Multiple independent origins of Shigella clones of Escherichia coli and convergent evolution of many of their characteristics. Proceedings of the National Academy of Sciences of USA 97:10567–10572. doi: 10.1073/pnas.180094797.
107. Rangel JM, Sparling PH, Crowe C, Griffin PM, Swerdlow DL. 2005. Epidemiology of Escherichia coli O157:H7, 1982–2002. Emerging Infectious Diseases 11: 603–609. doi: 10.3201/eid1104.040739.
108. Roberts RJ. 2005. How restriction enzymes became the workhorses of molecular biology. Proceedings of the National Academy of Sciences of USA 102:5902–5908. doi: 10.1073/pnas.0500923102.
109. Robinson CM, Sinclair JF, Smith MJ, O’Brien AD. 2006. Shiga toxin of enterohemorrhagic Escherichia coli type O157:H7 promotes intestinal colonization. Proceedings of the National Academy of Sciences of USA 103:9667–9672. doi: 10.1073/pnas.0602359103.
110. Rudi K, Storrø O, Øien T, Johnsen R. 2012. Modelling bacterial transmission in human allergen-specific IgE sensitization. Letters in Applied Microbiology 54: 447–454. doi: 10.1111/j.1472-765X.2012.03229.x.
111. Russo TA, Johnson JR. 2003. Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly endemic problem. Microbes and Infection 5:449–456. doi: 10.1016/S1286-4579(03)00049-2.
112. Sannasiddappa TH, Costabile A, Gibson GR, Clarke SR. 2011. The influence of Staphylococcus aureus on gut microbial ecology in an in vitro continuous culture human colonic model system. PLOS ONE 6:e23227. doi: 10.1371/journal.pone.0023227.
113. Savageau MA. 1983. Escherichia coli habitats, cell types, and molecular mechanisms of gene control. The American Naturalist 122:732–744. doi: 10.1086/284168.
114. Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson M, Roy SL, Jones JL, Griffin PM. 2011. Foodborne illness acquired in the United States – major pathogens. Emerging Infectious Diseases 17:7–15. doi: 10.3201/eid1701.091101p1.
115. Schaechter M, Neidhardt FC. 1987. Indroduction. In: Neidhardt FC, editor. Escherichia coli and Salmonella typhimurium. Washington: American Society for Microbiology Press. p. 1–2.
116. Schluter J, Foster KR. 2012. The evolution of mutualism in gut microbiota via host epithelial selection. PLOS Biology 10:e1001424. doi: 10.137/journal.pbio.1001424.
117. Schmidt H, Hensel M. 2004. Pathogenicity islands in bacterial pathogens. Clinical Microbiology Reviews 17: 14–56. doi: 10.1128/CMR.17.1.14-56.2004.
118. Sears HI, Brownlee I, Uchiyama JK. 1950. Persistence of individual strains of E. coli in the intestinal tract of man. Journal of Bacteriology 59:293–301.
119. Shah D, Zhang Z, Khodursky AB, Kaldalu N, Kurg K, Lewis K. 2006. Persisters: a distinct physiological state of E. coli. BMC Microbiology 6:53. doi: 10.1186/1471-2180-6-53.
120. Shoaie S, Kalrsson F, Mardinoglu A, Nookaew I, Bordel S, Nielsen J. 2013. Understanding the interactions between bacteria and the human gut through metabolic modeling. Scientific Reports 3:2532. doi: 10.1038/srep02532.
121. Shulman ST, Friedmann HC, Sims RH. 2007. Theodor Escherich: the first pediatric infectious diseases physician? Clinical Infectious Diseases 45:1025–1029. doi: 10.1086/521946.
122. Smith KE, Wilker PR, Reiter PL, Hedican EB, Bender JB, Hedberg CW. 2012. Antibiotic treatment of Escherichia coli O157 infection and the risk of hemolytic uremic syndrome, Minnesota. Pediatric Infectious Disease Journal 31:37–41. doi: 10.1097/INF.0b013e31823096a8.
123. Stevens A. 1960. Incorporation of the adenine ribonucleotide into RNA by cell fractions from E. coli. Biochemical and Biophysical Research Communications 3:92–96. doi: 10.1016/0006-291X(60)90110-8.
124. Tenaillon O, Skurnik D, Picard B, Denamur E. 2010. The population genetics of commensal Escherichia coli. Natures Reviews Microbiology 8:207–217. doi: 10.1038/nrmicro2298.
125. Texier S, Prigent-Combaret C, Gourdon MH, Poirier MA, Faivre P, Dorioz JM, Poulenard J, Jocteur-Monrozier L, Moenne-Loccoz Y, Trevisan D. 2008. Persistence of culturable Escherichia coli fecal contaminants in dairy Alpine grassland soils. Journal of Environmental Quality 37:2299–2310. doi: 10.2134/jeq2008.0028.
126. Tomas J, Reygner J, Mayeur C, Ducroc R, Bouet S, Bridonneau C, Cavin J, Thomas M, Langella P, Cherbuy C. 2015. Early colonizing Escherichia coli elicits remodeling of rat colonic epithelium shifty toward a new homeostatic state. The ISME Journal 9:46–58. doi: 10.1038/ismej.2014.111.
127. Touchon M, Hoede C, Tenaillon O, Barbe V, Baeriswyl S, Bidet P, Bingen E, Bonascorsi S, Bouchier C, Bouvet O, et al. 2009. Organised genome dynamics in the Escherichia coli species results in high diverse adaptive paths. PLOS Genetics 5:e1000344. doi: 10.1371/journal.pgen.1000344.
128. Travisano M, Mongold JA, Bennet AF, Lenski RE. 1995. Experimental tests of the roles of adaptation, chance and history in evolution. Science 267:87–90. doi: 10.1126/science.7809610.
129. Tyerman JG, Ponciano JM, Joyce P, Forney LJ, Harmon LJ. 2013. The evolution of antibiotic susceptibility and resistance during the formation of Escherichia coli biofilms in the absence of antibiotics. BMC Evolutionary Biology 13:22. doi: 10.1186/1471-2148-13-22.
130. van Elsas JD, Semenov AV, Costa R, Trevors JT. 2011. Survival of Escherichia coli in the environment: fundamental and public health aspects. The ISME Journal 5:173–183. doi: 10.1038/ismej.2010.80.
131. Virgin HW. 2014. The virome in mammalian physiology and disease. Cell 157:142–150. doi: 10.1016/j.cell.2014.02.032.
132. Vogeleer P, Tremblay YD, Mafu AA, Jacques M, Harel J. 2014. Life on the outside: role of biofilms in environmental persistence of Shiga-toxin producing Escherichia coli. Frontiers in Microbiology 5:317. doi: 10.3389/fmicb.2014.00317.
133. Walk ST, Alm EW, Gordon DM, Ram JL, Toranzos GA, Tiedje JM, Whittam TS. 2009. Cryptic lineages of the genus Escherichia. Applied and Environmental Microbiology 75:6534–6544. doi: 10.1128/AEM.01262-09.
134. Wang X, Rochon M, Lamprokostopoulou H, Lünsdorf H, Nimitz M, Römling U. 2006. Impact of biofilm matrix components of commensal Escherichia coli with the gastrointestinal cell line HT-29. Cellular and Molecular Life Sciences 63:2352–2363. doi: 10.1007/s00018-006-6222-4t.
135. Welch RA, Burland V, Plunkett G III, Redford P, Roesch P, Rasko D, Buckles EL, Liou SR, Boutin A, Hackett J, et al. 2002. Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proceedings of the National Academy of Sciences of USA 99:17020–17024. doi: 10.1073/pnas.252529799.
136. Werkman CH. 1927. Vitamin effects in the physiology of microorganisms. Journal of Bacteriology 14:335–347.
137. Winfield MD, Groisman EA. 2003. Role of nonhost environments in the lifestyles of Salmonella and Escherichia coli. Applied and Environmental Microbiology 69:3687–3694. doi: 10.1128/AEM.69.7.3687-3694.2003.
138. Wiser MJ, Ribeck N, Lenski RE. 2013. Long-term dynamics of adaptation in asexual populations. Science 342:1364–1367. doi: 10.1126/science.1243357.
139. Wollman E. 1925. Recherches sur la bacteriophagie (phenomene de twort-d’Herelle). Annales de l’Institut Pasteur 56:137–164.
140. Wollman E, Wollman E. 1937. The phases of bacteriophages. Comptes Rendus Hebdomadaires Des Séances Et Mémoires De La Socié te´ De Biologie (Proceedings of the Academy of Sciences and Minutes of the Society of Biology) 124:931–934.
141. Zhang R, Turner L, Berg HC. 2010. The upper surface of an Escherichia coli swarm is stationary. Proceedings of the National Academy of Sciences of USA 107:288–290. doi: 10.1073/pnas.0912804107.
142. Zhang Y. 2014. Persisters, persistent infections and the Yin-Yang model. Emerging Microbes and Infections 3: e3. doi: 10.1038/emi.2014.3.
143. Zimmer C. 2008. Microcosm. New York: Pantheon Books.